F = Finance by Kc Kc et al.
DSC Notice: 25/99/P18 
Date of Issue: January 2000 
Subject: 
Cervical Screening Statistics – 
Revision of Central Statistical
Returns: 
KC53 & KC61  CRIR 
Committee for Regulating 
Information Requirements  Implementation date:  1 April 2000 
DATA SET CHANGE CONTROL PROCEDURE 
This paper gives notification of changes approved by CRIR which will be included in 
the NHS Data Dictionary, the NHS Data Manual and the NHS CDS Manual in due 
course. 
Summary of change: 
Enhancements to KC53 & KC61 including the collection of data by relevant population 
(PCG based) in place of resident population, to improve the information available for 
monitoring the NHS Cervical Screening Programme. 
Summary of impact: 
KC53:

Changes to Health Authority computer systems and familiarisation training for HA

administrative staff.

KC61:

Changes to computer programmes to enable extraction of additional information.

Awareness training for laboratory staff on the changes to the forms and computer

systems.

Change Proposal Reference 
No:CP31/99 
Please address enquiries about this DSCN to the CRIR Secretariat, NHS Information Authority, 15 Frederick 
Road, Birmingham B15 1JD Tel: 0121 335 4461 or to the nominated enquiry point. 
Data Set Change Notices are located on the Internet in the Electronic Library at 
http://www.standards.nhsia.nhs.uk/library/index.htm and on the NHSnet at 
http://nww.standards.nhsia.nhs.uk/library/index.htm 
DSCN numbering format = sequence number/year of issue/service identifier and service sequence number. The service identifier 
and sequence number enables you to check that you have a complete set of service-specific DSCNs. 
Key to Service Identifier: 
A = All Services

P = Patient (Hospital, Community, Cross Sector Services)

F = Finance

E = Estates

W = Workforce

T = Transport
DATA SET CHANGE NOTICE 25/99/P18

Reference: 
Version No: 
Subject: 
Type of Change: 
Reason for Change: 
Effective Date: 
CP31/99 
V1.1 
Cervical Screening Statistics – 
Revision of Central Statistical returns: 
KC53 & KC61 
Revisions to existing Central 
Returns 
Recommendations of Expert Working 
Group set up to perform triennial 
review of central returns KC53 and 
KC61 
1 April 2000 
Effect on Central Returns Various enhancements to KC53 & KC61 including the

collection of data by relevant population (PCG based) in place of

resident population.  Copies of the returns are attached for information.

1.  Introduction: 
Central Statistical Returns KC53 and KC61 have been revised to improve the information 
available for monitoring the NHS Cervical Screening Programme. 
2.  Background: 
The central statistical returns Working Group confirmed the continuing need for 
returns KC53 and KC61 because they are necessary to monitor the NHS Cervical 
Screening Programme (NHSCSP) which contributes to the Government’ s target of 
reducing the incidence of invasive cervical cancer. The changes affect the detail of the 
information already collected. Those to the KC53 are to report additional information, 
which is available from the current database, for monitoring the effectiveness of 
cervical screening programme particularly among older women. 
The KC61 has been amended to collect information about the test results in more 
detail.  Full details of the changes are in Annex 1 to this change notice.  Annex 2 
contains the revised forms for information. 
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The revised returns are introduced for the collection of data for the financial year 
2000-2001. 
4.  Argument: 
Cervical screening started in the 1960s when a number of local screening programmes 
were implemented.  By the 1980s it was clear that an effective, well managed, national 
screening programme was required to replace the many local programmes that had 
been developed on an ad hoc basis.  In 1988 the Department required each health 
authority to introduce a cervical screening programme to offer all women aged 20 to 
64 a smear at least every 5 years. 
Both existing returns are required, as they are used for different purposes. The KC53 
monitors the call and recall system established by health authorities for women aged 
20 to 64 and shows the percentage of women tested and those who have some 
abnormality identified. The KC61 relates to laboratory activity and gives some 
indication of whether or not laboratories are following the criteria for the identification 
of different types of abnormality.  The results of the latest analysis of these returns 
were published in January 1999 by the Department in the Statistical Bulletin "Cervical 
Screening Programme, England: 1997-98". 
A number of meetings of the Working Group were held. The group included 
representatives from the Department's statistical and policy sections responsible for 
cervical screening, the National Co-ordinator of the NHS Cervical Screening 
Programme, 2 consultant pathologists and a representative from a cytology laboratory, 
a regional QA co-ordinator, representatives from health authority cervical screening 
programmes, a representative of the British Society for Colposcopy and Cervical 
pathology, and members of the NHS Information Authority.  The group therefore had 
representation from both Departmental and NHS users, and from the computer unit 
responsible for implementing changes to KC53. 
5.  Impact: 
KC53 
All HAs in England use the same computer system for producing the KC53 return. 
Developments to the system are planned and funded centrally and are carried out by 
the NHS Information Authority. 
The NHS Information Authority representatives on the Central Statistical Returns 
Working Group confirmed that the changes to the KC53 will have little impact on the 
collection of data at a local level. 
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It is not appropriate for the NHS Information Authority to undertake reprogramming of 
the KC61 as there is no common computer programme used in the 170 pathology 
laboratories in England. Many individual and proprietary systems have been 
developed. 
Unlike the KC53 changes, which will involve rewriting the software programme, the 
KC61 changes involve extracting additional information already held on laboratory 
computer systems. 
Data collection in laboratories is carried out by a combination of administrative, 
scientific and clinical staff, and varies from laboratory to laboratory. In addition to the 
changes to the computer programmes, staff will have to learn the revisions to the 
forms and changes to their computer systems. 
6.  Summary: 
There is considerable interest in the NHS Cervical Screening Programme and the KC53 
and KC61 statistical returns are essential for monitoring the progress of the programme 
and its quality.  The revisions will improve the information that is available for 
monitoring the call and recall programme and the outcomes of tests 
7.  Clearance: 
ROCR and PS(H) have agreed the revised data collection. 
8.  Additional Information: 
For further information contact: 
Paul Davies

Statistics Division (SD2B)

Department of Health

Skipton House

80 London Road

SE1 6LH

Tel: 0171 972 5697

Fax: 0171 972  5662

Andrea L Pearson

NHSCSP

The Manor House

260 Ecclesall Road South

Sheffield

S11 9PS

Tel: 0114 271 1060

Fax: 0114 271 1089
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DETAILS OF CHANGES RECOMMENDED BY WORKING GROUP 
KC53 
1.  A sample copy of the revised return is attached. (Annex 2) 
Part A2 (New): status of health authority relevant population 
2.  The existing Part A2 has been split into 2 parts, the first part (new Part A2) to 
include existing columns (2), (3), (4) and (5), and a further column (6) headed: 
“Eligible population”  (to be calculated from column (2) less (3) only i.e. 
women with recall ceased for clinical reasons). 
3.  It was confirmed that health authorities will need to estimate their population 
base to the relevant population composed of Primary Care Groups.  That is: ALL those 
patients resident within the health authority boundary; PLUS all patients registered 
with GPs who form part of PCGs for which the health authority are responsible, but 
who are resident elsewhere; MINUS residents registered with GPs who form part of 
PCGs responsible to another health authority. It was noted that CIC returns would be 
completed on this basis in the future. Column 2 has therefore been amended to refer 
to: 
“Number of women in Health authority relevant population.” 
The NHS Information Authority and NHSCSP confirmed that the change could be 
financed and completed in the financial year 1999-2000. 
4.  There was interest in the testing of older women and it was agreed to identify 
separately the age group 75-79. 
Part A3(New): Number of women screened by time since last test 
5.  The screening programme has been running for a number of years and 
NHSCSP require information about women “ever”  screened in their lifetime to judge 
the effectiveness of the screening programme. Present records went back to 1988. A 
new Part A3, therefore, has been introduced to collect information specifically about 
the number of women screened by the time since last test. It includes information 
already collected about number of women tested in last 3 years. The column about 
number of women tested in the last 5 years has been modified to collect information 
about the number of women tested: 
“more than 3 years ago but not more than 5 years ago.” 
Additional columns have been included to obtain information on the number of 
women last tested -
“more than 5 years ago but not more than 10 years ago; 
more than 10 years ago but not more than 15 years ago; and 
more than 15 years ago.” 
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6.  A minor change only; the words “… and may include some clinically indicated 
screens.”, to be deleted from Notes for column 8. 
Part E (New): Notification of result – waiting times 
7.  There is considerable ministerial interest in the time that women have to wait 
from having a test to the time they received their result. This matter has also been 
raised by the NAO, at PAC hearings, and in Parliamentary Questions. The difficulties 
in providing this information is understood but the delay in advising results needs to 
be monitored in order to reduce anxiety among women who have had a cervical 
smear test. Part E has therefore been introduced to ensure that this information is 
available. 
8.  The national standard to be achieved is that women should be advised in 
writing of the result of their test 4 weeks from the date the test was taken. The time 
taken is based on calendar days. The return counts all tests and not just the most 
severe result. Only screening programme smears are included. Details on the length of 
delays would provide information on how well screening programmes were working 
locally and also the performance of laboratories. (Information about the time taken to 
authorise laboratory reports will also be collected on KC61 – see para 15 > below.) 
9.  There is considerable variation in the dates used for receipt of tests and the 
organisation of the notification of results. Generally health authorities should be 
responsible for sending out result letters. But where laboratories are responsible for 
notifying results the health authority would not have information about the delay 
between the women having the test and receiving the result.  Also some laboratories 
hold back results in order that the GPs could be advised of the result before the 
woman. The Department will be issuing instructions later this year to health 
authorities about the notification of test results including the maximum time from 
producing the report to sending it out and, avoiding women receiving an abnormal 
result on a Saturday. 
10.  The KC53 software reports information about delays from the system if the 
arrangements locally are that the health authority sends out the results. 
Part F (New): Test/recall status of women following most severe screening test 
result in the year. 
11.  An additional part has been included in the KC53 to collect information about 
the action taken following a woman’ s most severe test result in a year. The 
information about the numbers of women classified by each result and action code 
will be helpful to the NHSCSP to establish a national picture of action taken. 
12.  The action codes to be monitored are Recall (A), Suspend (S) and Repeat (R) 
against result codes 1 to 8 from HMR 101/5. Form HMR 101/5 is an operational 
document used by most laboratories on which they code the results of cervical 
smears. The women to be included in this return are those from the NHSCSP only, age 
20-64. 
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13.  A sample copy of the revised return is attached. (Annex 2). 
Part A 
14.  Existing Part A has been renumbered Part A1. 
Part A2: Laboratory processing: from receipt of smears to authorisation of 
report 
15.  Part A2 has been introduced to collect information about the backlog of smears 
in laboratories. This information has been collected in the past but because of 
problems in collecting the data it had been dropped. However the information is 
required to monitor the performance of laboratories. It is recognised that there are 
various reasons why laboratories accumulate a backlog. 
16.  Information for each quarter is required. The interval to be reported is from the 
date of receipt of smear at laboratory and date of authorisation of final report. 
Guidance will make clear that the smear should be dated immediately on receipt at 
laboratory. 
Part A3: Number of smears primary screened for/by another laboratory. 
17.  As some smears are sent from one laboratory to another for examination this 
information is required. Part A3 has therefore been introduced to record information 
about the numbers of imported and exported smears dealt with by laboratories and 
also the number of instances where more than one sample was checked from a single 
smear prepared 
18.  Current guidance is that the receiving laboratory should count and report on the 
smear. Information is to be recorded about smears “processed”  and not “primary 
screened”. The Department will ensure that the guidance is strengthened in connection 
with the treatment by laboratories of imported smears. 
Part C 
19.  The year 1998 has been removed from the heading. The amended heading is 
"Outcome by 31 March yyyy for women recommended for gynaecological referral 
where the smear was registered during April- June yyyy". The actual date will be stated 
on the form when it is distributed by SD2B in the Department. 
20.  The screening programme is primarily concerned to detect cervical cancers and 
line 0001 has been amended to read; 
“Cervical cancer (including micro-invasive)”. 
An additional line 0011 has been included to record 
“Non cervical cancers detected”. 
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smear even though these findings were incidental to the Cervical Screening 
Programme. 
21.  For clarity line 0010 has been amended from “Result not known”  to “Result not 
known by laboratory”. 
22.  Part C also includes the formula to calculate the Positive Predictive Value of 
smears reported as moderate dyskaryosis or worse to enable the laboratory to calculate 
whether or not they are reaching an achievable standard. Calculation of PPV is subject 
to change by the ABC (Achievable standards, Benchmarks for reporting and Criteria for 
evaluating cervical cytopathology) Group. The Department, in consultation with 
NHSCSP, would write direct to laboratories should the formula for calculating PPV 
change. 
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DH FORM  ADULT SCREENING PROGRAMMES: CERVICAL SCREENING  KC53 
Year ending 31 March yyyy 
Health Authority code  Q 
Health Authority name 
Name of contact 
Telephone 
If you have any queries regarding completion of this form, please contact SD2B 
Telephone 0171 972 5697 
FAX  0171 972 5662 
Return to Department of Health 
Statistics Division 2B 
Room 430B 
Skipton House 
Elephant and Castle 
London 
SE1 6LH 
For NHS use. Please use this space to record anything relevant to the quality or consistency of the data. 
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0002
0003
0004
0005
0006
0007
0008
0009
0010
0011
0012
0013
0014
DH FORM  PART  A  CERVICAL SCREENING PROGRAMME  KC53 
STATUS OF HEALTH AUTHORITY RELEVANT POPULATION 
PART  A1 
Routine recall interval in use in the Health Authority (TICK ONE BOX ONLY) 
(1) 
Please 
specify:............................... 
PART  A2 
(1)  (2)  (3)  (4)  (5)  (6) 
0001  5 YEARS 
0002  4 YEARS 
0003  3 YEARS 
0004  3 AND 5 YEARS MIXED 
0005  OTHER 
Line 
number 
Age of 
woman at 
31 March 
Number of 
women in Health 
Authority relevant 
population 
Number of women with recall ceased for 
Eligible 
population 
clinical 
reasons 
(no cervix) 
age 
reasons 
other 
reasons 
Under 20 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75-79 
80 & over 
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0002
0003
0004
0005
0006
0007
0008
0009
0010
0015  Target age 
group 
(25-64) 
9999 
Total 
all 
ages 
In column (6) record women in the Health Authority relevant population less those who 
are recall ceased for clinical reasons, i.e. col.2 - col 3 
DH  PART A3  CERVICAL 
FORM  SCREENING 
PROGRAMME 
KC53 
NUMBER OF WOMEN SCREENED BY 
TIME SINCE LAST TEST 
(1)  (2)  (3)  (4)  (5)  (6)  (7) 
Line 
number 
Age of 
woman 
at 
31 March 
Number of 
women 
last tested in 
the last 3 years 
Number of women 
last tested more than 
3 years ago, but not 
more than 5 years ago 
Number of 
women 
last tested more 
than 
5 years ago, but 
not 
more than 10 
years ago 
Number of 
women 
last tested 
more than 
10 years 
ago, but not 
more than 
15 years ago 
Number of 
women 
last tested 
more than 
15 years ago 
Number of 
women with no 
cytology record 
Under 20 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
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0012  70-74 
0013  75-79 
0014  80 & 
over 
0015 
Target 
age 
group 
(25-64) 
9999 
Total 
all 
ages 
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0001
0002
0003
0004
0005
0006
0007
0008
0009
0010
0011
0012
0013
DH FORM  PART  B	 CERVICAL SCREENING  KC53 
PROGRAMME NUMBER OF 
WOMEN INVITED 
(1)  (2)  (3)  (4)  (5)  (6) 
Line 
number 
Age of 
woman at 
31 March 
Number of women invited in the year as a result of: 
Call  Routine recall 
Repeat in <3 years for reasons of 
Surveillance  Abnormality  Inadequate 
smear 
Under 20 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 & over 
0014 
Target 
age group 
(25-64) 
9999 
Total 
all 
ages 
Notes: 
In column (2) record those women invited for screening in the year as a result of a first call for screening (these women

will not have been screened before).

In column (3) record those women invited for screening in the year as a result of a routine recall. These women will

have had a previous negative result and been recalled after the usual interval (normally 3 or 5 years).

In columns (4) and (5) record those women invited for screening because their last smear was adequate, but a repeat

was advised. Normally these women will have had a previous abnormal smear.

In column (6) record those women invited for screening because their previous smear was inadequate.
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0002
0003
0004
0005
0006
0007
0008
0009
0010
0011
0012
0013
DH 
FORM 
PART 
C 
CERVICAL 
SCREENING 
PROGRAMM 
E 
KC53 
NUMBER OF WOMEN 
TESTED 
(2)  (3)  (4)  (5)  (6)  (7)  (8) 
Line 
number 
Age of 
woman at 
31 March 
Number of women 
tested in the year -
as a result of:  Repeat in <3 years for reasons of  While 
recall 
suspended 
Opportunistic 
screen Call  Routine 
recall 
Surveillance  Abnormality  Inadequate 
smear 
Under 20 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 & over 
0014 
Target 
age group 
(25-64) 
9999 
Total 
all 
ages 
In column (2) record those women  screened in the year as a result of a first call for screening, within the 12 
months following the original invitation being issued (these women will not have been screened before). 
DSCN 25/99/P18 
Page 14 of 26 In column (3) record those women screened in the year as a result of a routine recall within the 12 months

following the original invitation being issued.  These women will have had a previous negative result and been

recalled after the usual interval (normally 3 or 5 years).

In columns (4) and (5) record those women screened in the year because their last smear was adequate, but a

repeat was advised, within the 12 months following the recall invitation being issued. Normally these women will

have had a previous abnormal smear.

In column (6) record those women screened in the year because their previous smear was inadequate, within the

12 months following the recall invitation being issued. These women will have a Recall Type of "Inadequate".

In column (7) record those women screened in the year who were suspended from the call and recall system.

In column (8) record those women screened opportunistically in the year. These will be all women whose Recall

Status was "No action", "GP not informed", "GP informed" "ZZZ GP" and those women whose recall status was

"Final non-responder" -where the initial invitation was generated more than 12 months ago.
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0002
0003
0004
0005
0006
0007
0008
0009
0010
0011
0012
0013
DH FORM KC53  PART  D	 CERVICAL SCREENING PROGRAMME 
RESULT OF TEST 
KC53 
(1)  (2)  (3)  (4) 
Line 
number 
Age of woman at 
31 March 
Woman's most severe test result in the year 
(see categories in box 22 of form HMR 101/5) 
Negative 
(cat. 2) 
Borderline/ 
Mild dyskaryosis 
(cats. 3/8) 
Moderate 
dyskaryosis 
(cat. 7) 
Severe 
dyskaryosis 
(cats. 4/5/6) 
Under 20 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 & over 
0014 
Target 
age group 
(25-64) 
9999 
Total 
all 
ages 
Notes:	 This part concerns women for whom a test result was recorded 
during the year. Inadequate smears are not included. 
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0002
0003
0004
0005
0006
DH FORM  PART  E  CERVICAL SCREENING PROGRAMME  KC53 
NOTIFICATION OF RESULT - WAITING TIMES 
(1)  (2) 
Line 
number 
Number of weeks between date smear is taken 
and date result is sent from the Health Authority 
Number 
of tests 
Less than or equal to 4 weeks 
>4 weeks up to 6 weeks 
>6 weeks up to 8 weeks 
>8 weeks up to 10 weeks 
>10 weeks up to 12 weeks 
Over 12 weeks 
0007  Total 
0008  Letter not sent by Health Authority 
NHS Screening Programme smears only 
Line 8 - for use only where letters are sent directly by laboratory or by some 
other  agency which is not the Health Authority 
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FORM 
PART  F  Cervical Screening Programme 
Test Recall/Status of women following most Severe 
Screening result in the year 
Woman's most  Recall/Test action codes 
severe test in 
result in the 
year  Normal (A)  Suspend (S)  Repeat (R) 
Inadequate 
(cat. 1) 
Negative 
(cat. 2) 
Mild 
dyskaryosis 
(cat. 3) 
Severe 
dyskaryosis 
(cat. 4) 
? Invasive 
cancer 
(cat. 5) 
? Glandular 
neoplasia 
(cat. 6) 
dyskaryosis 
(cat. 7) 
Borderline 
changes 
(cat. 8) 
NHS Screening Programme women, (aged 20-64) only 
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FORM 
PATHOLOGY LABORATORIES - CERVICAL 
CYTOLOGY AND OUTCOME OF 
GYNAECOLOGICAL REFERRALS. 
KC61 
Year ending 31 March yyyy  (1) 
NHS Trust Name 
(3) 
Pathology Laboratory 
Name 
Name of contact 
NHS Trust  R 
A separate return is required for each 
pathology laboratory that carries out 
gynaecological cytology 
Pathology Laboratory 
Code 
Code  (2) 
Telephone 
If you have any queries regarding completion of this form, please contact SD2B

Telephone: 0171 972 5538  Fax : 0171 972 5662

Return to: Department of Health

Statistics Division 2B

Room 430B Skipton House

Elephant and Castle

London SE1 6LH

For NHS use. Please use this space to record anything 
relevant to the quality or consistency of the data. 
I confirm that these data are, to the best of my knowledge, an

accurate representation of the results obtained from the cervical

screening carried out at this laboratory.

Signed  Date

Consultant 
Pathologist 
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SOURCE OF SMEAR 
(1)  (2)  (3)  (4)  (5)  (6)  (7)  (8)  (9)  (10) 
Results of test 
Line  Source of 
smear 
Severe 
No.  (Box 9 of 
form 
Inadequate  Negative  Borderline  Mild  Moderate  Severe  dyskaryosis/  ?Glandular  Total 
HMR 
101/5) 
changes  dyskaryosis  dyskaryosis  dyskaryosis  ?Invasive  neoplasia  number 
(cat. 1)  (cat. 2)  (cat. 8)  (cat. 3)  (cat. 7)  (cat. 4)  carcinoma  (cat. 6)  examined 
(cat. 5) 
0001  GP 
0002  NHS 
Communit 
y 
Clinic 
0003  GUM 
0004  NHS 
Hospital 
0005  Private 
(See categories in box 22 of form HMR 101/5) 
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0006  Other 
Total of 
GP and 
NHS 
0007 Communit 
y Clinics 
Line 0001 
+ 0002 
0008  Grand 
Total 
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PART  A2	 LABORATORY  PART  A3 
BACKLOG 
TOTAL 
NUMBER 
OF SMEARS  NUMBER REPORTED (TO WOMAN 
OR HA) WITHIN 
REGISTERED  0-2 
weeks 
3-4 
weeks 
5-6 
weeks 
7-8 
weeks 
9 
weeks 
or 
more 
QUARTER 
1 
As at 30 
June yyyy 
QUARTER 
2 
As at 30 
September 
yyyy 
QUARTER 
3 
As at 31 
December 
yyyy 
QUARTER 
4 
As at 31 
March 
yyyy 
NUMBER OF SMEARS  PROCESSED 
FOR/BY ANOTHER LABORATORY 
NUMBER OF SMEARS SENT TO 
ANOTHER LABORATORY 
NUMBER OF SMEARS RECEIVED 
FROM ANOTHER LABORATORY 
WHERE MORE THAN ONE SMEAR IS TAKEN 
NUMBER OF INSTANCES WHERE 
MORE THAN ONE SAMPLE IS 
CHECKED FROM A SINGLE REPORT 
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FORM  CLINICS ONLY BY AGE GROUP OF WOMEN 
(1)  (2)  (3)  (4)  (5)  (6)  (7)  (8)  (9)  (10) 
Line 
No.  Age 
Results of test  (See categories in box 22 of form HMR 101/5) 
Total 
number 
examined 
Inadequate 
(cat 1) 
Negative 
(cat 2) 
Borderline 
changes 
(cat 8) 
Mild 
dyskaryosis  dyskaryosis  dyskaryosis 
(cat 3) 
Moderate 
(cat 7) 
Severe 
(cat 4) 
Severe 
dyskaryosis/ 
?Invasive 
carcinoma 
(cat 5) 
Glandular 
neoplasia 
(cat 6) 
0001  Under 
20 
0002  20-24 
0003  25-29 
0004  30-34 
0005  35-39 
0006  40-44 
0007  45-49 
0008  50-54 
0009  55-59 
0010  60-64 
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0012  70-74 
0013  75 and 
over 
0014  Total 
20-64 
Lines 
0002 -
0010 
0015  Grand 
Total 
NB: Total number examined as recorded in Part B should equal row 0007 in Part A 
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DH FORM  PART  C	 OUTCOME BY 31 MARCH YYYY FOR WOMEN  KC61 
RECOMMENDED FOR GYNAECOLOGICAL REFERRAL 
WHERE THE SMEAR WAS REGISTERED DURING APRIL -
JUNE YYYY 
(1)  (2)  (3)  (4)  (5)  (6)  (7)  (8) 
Line 
No.  Outcome of referral * 
Most significant result  (See categories in box 22 of form HMR 101/5) 
Total 
Inadequate 
(cat. 1) 
Borderline 
changes 
(cat. 8) 
Mild 
dyskaryosis 
(cat. 3) 
Moderate 
dyskaryosis 
(cat. 7) 
Severe 
dyskaryosis 
(cats. 4/5/6) 
0001 
Cervical cancer 
(including micro­
invasive) 
x  x 
0002  Adenocarcinoma in 
situ 
x  x 
0003  CIN3 
x  x 
0004  CIN2 
x  x 
0005  CIN1 
y  y 
0006  HPV only 
y  y 
0007  No CIN / No HPV 
y  y 
0008  Inadequate biopsy 
DSCN 25/99/P18 
Page 25 of 26 0009  Colposcopy NAD 
no biopsy taken 
0010  Result not known 
by laboratory 
0011  Non cervical cancers 
detected 
* Where more than one specimen is taken from the same woman the most  Positive Predictive Value (PPV) 
severe result only should be recorded

Total x

Total x + y  X 100  = %

PPV should be regarded as a guide for the audit of histology and cytology and is not a precise measure of accuracy 
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